{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-011291","form_type":"8-K","ticker":"OLMA","cik":"0001750284","company_name":"Olema Pharmaceuticals, Inc.","filed_at":"2023-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.375814+00:00","generated_at":"2026-06-13T20:09:38.324810+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Olema holds annual meeting; stockholders elect three directors, approve say-on-pay, ratify E&Y auditor","bullets":["Sean P. Bohen, Yi Larson, and Andrew Rappaport elected as Class III directors through 2026 with votes 23.5M, 18.0M, and 23.7M for respectively.","Advisory vote on executive compensation approved: 18.7M for, 1.9M against, 5.0M abstain, 5.8M broker non-votes.","Ratification of Ernst & Young as independent auditor for FY2023 approved: 30.9M for, 10k against, 540k abstain.","Broker non-votes of 5.8M shares present on director and compensation proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-011291","json":"https://secwatch.observer/filing/0001558370-23-011291.json","markdown":"https://secwatch.observer/filing/0001558370-23-011291.md","text":"https://secwatch.observer/filing/0001558370-23-011291.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/olma-20230615x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:09:38.324810+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"35756aade12c9dac506b7a6b85c564119f475d54","claim":"Olema Pharmaceuticals, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 3— Ratification of Selection of Independent Registered Public Accounting Firm Final Voting Results For Against Abstain 30,921,828 ​ ​ 10,323 ​ ​ ​ 540,055","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"b48cd2d8504b5c70cbf275010204b2c165af83a5","claim":"Olema Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 1— Election of Directors Final Voting Results Nominees For Withheld Broker Non-Votes Sean P. Bohen, M.D., Ph.D. 23,524,203 ​ ​ ​ 2,123,064 ​ ​ ​ 5,824,939 Yi Larson 17,980,507 ​ ​ ​ 7,666,760 ​ ​ ​ 5,824,939 Andrew Rappaport 23,727,247 ​ ​ ​ 1,920,020 ​ ​ ​ 5,824,939","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"d9624ed43665edf1e8bbfbf6206c32f7ec475578","claim":"Olema Pharmaceuticals, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-06-15 meeting.","evidence_excerpt":"Proposal 2— Advisory Vote on Executive Compensation Final Voting Results For Against Abstain Broker Non-Votes 18,713,603 ​ ​ 1,912,571 ​ ​ ​ 5,021,093 ​ ​ ​ 5,824,939","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}